Expert Discussions from the World of Retina: Exploring the latest developments in the field with world-renowned leaders. It will feature a monthly subspecialty journal club, panel discussions and interviews with key opinion leaders.
Episodes
Wednesday Jan 31, 2024
Wednesday Jan 31, 2024
Following the approval of Aflibercept 8mg, clinicians in Europe now have 5 anti-VEGF treatments to choose from, not to mention biosimilars. How should we treat patients with so many options open to us? Sandrine Zweifel (Switzerland) and Stela Vujosevic (Italy) compare notes
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.